ABDC News and Press, Alcentra Capital Corp. From 11/05/19

Alcentra (NASDAQ: ABDC ): Q3 GAAP NII of $0.13 misses by $0.05 . Total investment income of $5.6M (-14.5% Y/Y) misses by $0.58M . Press Release More news on: Alcentra Capital Corporation, Earnings news and commentary, Financial stocks news, ,

NEW YORK , Nov. 5, 2019 /PRNewswire/ -- Alcentra Capital Corporation (NASDAQ: ABDC) (the "Company"), a provider of debt financing solutions to middle-market companies based primarily in the United States , today announced its financial results for the third quarter of 2019. Third Qua...

Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...

NEW YORK , Oct. 14, 2019 /PRNewswire/ -- Alcentra Capital Corporation (NASDAQ: ABDC) ("Alcentra Capital" or the "Company"), a provider of debt financing solutions to middle-market companies based primarily in the United States , announced today that its Board of Directors declared a...

Merger activity increased last week with five new deals announced and five deals closing. Deal Statistics: New Deals: The acquisition of Dova Pharmaceuticals (DOVA) by Swedish Orphan Biovitrum AB (BIOVF) for $915 million. Under the terms of the agreement, Dova stockholders will ...

Merger activity remained unchanged last week with two new deals announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Alder BioPharmaceuticals (ALDR) by H. Lundbeck A/S for $1.95 billion. Under the terms of the agreement, Alder stockholders will be of...

Merger activity increased last week with two new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of United Community Financial (UCFC) by First Defiance Financial (FDEF) for $473 million in an all-stock deal. Under the terms of the merger agre...

NEW YORK , Aug. 17, 2019 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City , is investigating: Presidio, Inc. ( PSDO ) ("Presidi...

It's been over a year since the 8/9/2018 announcement that Medley Management ( MDLY ) and Medley Capital ( MCC ) were planning to merge with Sierra Income to form the 2nd largest internally managed Business Development Corporation. These are all related companies. MDLY now manages both MCC...

Deciphera Pharmaceuticals (NASDAQ: DCPH ) +121%  on positive late-stage ripretinib data . More news on: Deciphera Pharmaceuticals, Inc., DelMar Pharmaceuticals, Inc., Alcentra Capital Corporation, Stocks on the move, Read more ...